» Articles » PMID: 2686127

5-HT1C Receptor Activation: a Key Step in the Initiation of Migraine?

Overview
Specialty Pharmacology
Date 1989 Aug 1
PMID 2686127
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Immunologic aspects of migraine: A review of literature.

Salahi M, Parsa S, Nourmohammadi D, Razmkhah Z, Salimi O, Rahmani M Front Neurol. 2022; 13:944791.

PMID: 36247795 PMC: 9554313. DOI: 10.3389/fneur.2022.944791.


Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor.

Wang Q, Zhou Y, Huang J, Huang N Pharmaceuticals (Basel). 2021; 14(2).

PMID: 33498477 PMC: 7909583. DOI: 10.3390/ph14020076.


The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.

Park H, Lee S, Shim J, Kim B, Hwang S, Kim S J Clin Neurol. 2010; 2(4):246-51.

PMID: 20396527 PMC: 2854974. DOI: 10.3988/jcn.2006.2.4.246.


Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.

Dunlop J, Marquis K, Lim H, Leung L, Kao J, Cheesman C CNS Drug Rev. 2007; 12(3-4):167-77.

PMID: 17227285 PMC: 6506193. DOI: 10.1111/j.1527-3458.2006.00167.x.


The effects of 5-HT and m-chlorophenylpiperazine (m-CPP) on the efflux of [3H]-5-HT from human perfused platelets.

Carver J, Grahame-Smith D, Johnson E, Madgwick Z Br J Clin Pharmacol. 1993; 35(5):473-8.

PMID: 8512759 PMC: 1381684. DOI: 10.1111/j.1365-2125.1993.tb04172.x.